India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
On 23rd to 24th June, 2026 in Bengaluru India hosting the BRICS Heads of Space…
India has secured the 13th position in the QS World Future Skills Index of 2027…
The latest International Monetary Fund (IMF) World Economic Outlook Report which released in the April…
The FIFA World Cup 2026 group stage is heating up after the first round of…
The Government of Uttar Pradesh has introduced and expanded several welfare and development schemes in…
The Belgian theoretical physicist François Englert who discovered the groundbreaking work which had laid the…